Multiparametric MRI of the prostate is now recommended as the initial diagnostic test for
men presenting with suspected prostate cancer, with a negative MRI enabling safe …

Simple Summary US-MRI fusion biopsy is established as a technique of reference for the
detection of clinically significative prostate cancer compared to the ultrasound “template” …

Background Prostate magnetic resonance imaging (MRI) is now standard for assessment of
suspected prostate cancer (PCa). A variety of approaches to MRI-based targeting has …

Prostate MRI is now established as a first-line investigation for individuals presenting with
suspected localized or locally advanced prostate cancer. Successful delivery of the MRI …

Simple Summary With the consolidation of multiparametric resonance of the prostate as an
effective method in the diagnosis of clinically significant prostate cancer (csPCa), robot …

Introduction Clinically significant prostate cancer (csCaP) with Gleason≥ 3+ 4 is found in
10% negative prebiopsy multiparametric (mp) MRI cases and varies widely for equivocal …

Background The optimal diagnostic pathway for prostate cancer (PCa) is evolving, requiring
further evaluation in a randomized controlled trial. Purpose To assess the diagnostic …

Objectives MRI is now established for initial prostate cancer diagnosis; however, there is no
standardized pathway to avoid unnecessary biopsy in low-risk patients. Our study aimed to …

Results Patients referred included 648 in 2009 and 714 in 2018. mpMRI seldomly informed
decision to biopsy in 2009 (9.8%), while in 2018 it was performed in the pre-biopsy setting in …

Prostate cancer (PCa) is a prevalent male malignancy that originates in the epithelial cells of
the prostate. In terms of incidence and mortality of malignant tumors in men, PCa ranks …